Skip to main content
Log in

Häufige und seltene dermatologische Erkrankungen bei HIV-Patienten

Frequent and rare dermatological diseases in HIV patients

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

HIV-Patienten leiden an einer großen Zahl infektiöser und nichtinfektiöser Haut- und Schleimhauterkrankungen, einige davon besitzen Markerfunktion für ein schwächer werdendes Immunsystem. Obwohl keine der dermatologischen Komplikationen pathognomonische Bedeutung besitzt, müssen z. B. die orale Haarleukoplakie, der Herpes zoster, die orale Kandidose bzw. die eosinophile Follikulitis Ofuji bei entsprechenden Patienten an eine HIV-Infektion denken lassen. Der Verdacht auf HIV besteht auch, wenn eine der aufgeführten Dermatosen atypisch oder besonders schwer verläuft bzw. schlecht auf eine geeignete Therapie anspricht. Die wesentlichsten häufigen und seltenen Dermatosen werden diskutiert.

Abstract

HIV patients develop a variety of infectious and non-infectious diseases of the skin and mucous membranes. Some of these serve as indicator diseases for a weakening immune system. While none of the dermatological complications is pathognomonic, conditions such as oral hairy leukoplakia, herpes zoster, thrush, and eosinophilic folliculitis should make physicians consider the possibility of underlying HIV disease. Moreover, one has to consider HIV if these skin diseases take an atypical or severe course, or if they do not respond properly to appropriate medication. Frequent and rare dermatoses occurring in HIV infection are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4a,b
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10
Abb. 11
Abb. 12
Abb. 13
Abb. 14
Abb. 15
Abb. 16
Abb. 17
Abb. 18
Abb. 19
Abb. 20
Abb. 21
Abb. 22
Abb. 23
Abb. 24
Abb. 25
Abb. 26

Literatur

  1. Amerio P, Verdolini R, Proietto G et al. (2001) Role of Th2 cytokines, RANTES, and eotaxin in AIDS associated eosinophilic folliculitis. Acta Derm Venereol 81: 92–95

    Article  PubMed  Google Scholar 

  2. Bachelez H, Hadida F, Gorochov G (1996) Massive infiltration of the skin by HIV-specific cytotoxic CD8+ T cells. N Engl J Med 335: 61–62

    Article  Google Scholar 

  3. Bär A, Hantschke D, Mirmohammadsadegh A, Hengge UR (2003) Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections (SSTI): emergence of methicillin-resistant Staphylococci. AIDS 17: 1253–1256

    Article  PubMed  Google Scholar 

  4. Barbagallo J, Tager P, Ingleton R et al. (2002) Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 3: 319–328

    Article  PubMed  Google Scholar 

  5. Brown DR, Schroeder JM, Bryan JT et al. (1999) Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37: 3316–3322

    PubMed  Google Scholar 

  6. Chiao EY, Krown SE, Stier EA, Schrag D (2005) A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 40: 451–455

    Article  PubMed  Google Scholar 

  7. Chin-Hong PV, Palefsky JM (2002) Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 35: 1127–1134

    Article  PubMed  Google Scholar 

  8. Clifford GM, Polesel J, Rickenbach M et al. (2005) Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425–432

    PubMed  Google Scholar 

  9. Ellis E, Scheinfeld N (2004) Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol 5: 189–197

    Article  PubMed  Google Scholar 

  10. Engels EA, Frisch M, Goedert JJ et al. (2002) Merkel cell carcinoma and HIV infection. Lancet 359: 497–498

    Article  PubMed  Google Scholar 

  11. Fidel PL Jr (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 19: 80–84

    PubMed  Google Scholar 

  12. Foucault C, Brouqui P, Raoult D (2006) Bartonella quintana characteristics and clinical management. Emerg Infect Dis 12: 217–223

    PubMed  Google Scholar 

  13. Franceschi S, Dal Maso L, Arniani S et al. (1998) Risk of cancer other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 78: 966–970

    PubMed  Google Scholar 

  14. Franceschi S, Bidoli E, Herrero R, Munoz N (2000) Comparison of cancers of the oral cavity and pharynx worlwide: etiological clues. Oral Oncol 36: 106–115

    Article  PubMed  Google Scholar 

  15. Frisch M, Glimelius B, Van den Brule AJ et al. (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337: 1350–1358

    Article  PubMed  Google Scholar 

  16. Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92: 1500–1510

    Article  PubMed  Google Scholar 

  17. Gibbs S, Harvey I, Sterling JC, Stark R (2001, 2003) Local treatments for cutaneous warts. Cochrane Database Syst Rev 3: CD001781

    Google Scholar 

  18. Gnann JW Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis [Suppl 1] 186: S91–S98

  19. Goedert JJ, Cote TR, Virgo P et al. (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833–1899

    Article  PubMed  Google Scholar 

  20. Goldie SJ, Kuntz KM, Weinstein MC et al. (1999) The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281: 1822–1829

    Article  PubMed  Google Scholar 

  21. Gross G (2004) Herpes simplex virus infections. Hautarzt 55: 818–830

    Article  PubMed  Google Scholar 

  22. Guitart J, Variakojis D, Kuzel T, Rosen S (1999) Cutaneous CD8 T cell infiltrates in advanced HIV infection. J Am Acad Dermatol 41: 722–727

    Article  PubMed  Google Scholar 

  23. Gupta AK, Bluhm R (2004) Seborrheic dermatitis. J Eur Acad Dermatol Venereol 18: 13–26

    Article  PubMed  Google Scholar 

  24. Gupta AK, Taborda P, Taborda V et al. (2000) Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 39: 746–753

    Article  PubMed  Google Scholar 

  25. Handa S, Bingham J (2001) Dermatological immune restauration syndrome: does it exist? J Eur Acad Dermatol Venereol 15: 430–435

    Article  PubMed  Google Scholar 

  26. Hengge UR (1999) Die oropharyngeale Candidose. In: Jäger (Hrsg) Mit AIDS leben – Prävention, Therapie Behandlungsalternativen, psychosoziale Aspekte 1999. Ecomed, Landsberg, S 100–102

  27. Hengge UR (2003) HPV-Infektion in der Dermastologie: Besonderheiten bei Organtransplantierten und HIV-Patienten. In: Hengge UR (Hrsg) HPV-Infektion und Neoplasien der Haut. Unimed, Bremen, S 50–60

  28. Hengge UR (Hrsg) (2003) HPV-Infektion und Neoplasien der Haut. Unimed, Bremen

  29. Hengge UR (2004) Papillomavirus diseases. Hautarzt 55: 841–854

    Article  PubMed  Google Scholar 

  30. Hengge U, Ruzicka T (Hrsg) (2006) Lehrbuch der Dermatologie und Venerologie. Ihr roter Faden durchs Studium nach der neuen ÄAppO. Wissenschaftliche Verlagsgesellschaft, Stuttgart

  31. Hengge UR, Tietze M (2000) Successful treatment of recalcitrant condyloma with topical cidofovi. Sex Transm Inf 76: 143

    Article  Google Scholar 

  32. Hengge UR, Brockmeyer NH, Baumann M et al. (1993) Liposomal doxorubicin treatment of AIDS-related Kaposi’s sarcoma. Lancet 342: 497

    Article  PubMed  Google Scholar 

  33. Hengge UR, Esser S, Schultewolter T et al. (2000) Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 143: 1026–1031

    Article  PubMed  Google Scholar 

  34. Hengge UR, Franz B, Goos M (2000) Decline of infectious skin manifestations in the era of highly active antiretroviral therapy. AIDS 14: 1069–1070

    Article  PubMed  Google Scholar 

  35. Hengge UR, Ruzicka T, Tyring S et al. (2002) Update on Kaposi’s sarcoma and other HHV-8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2: 281–292

    Article  PubMed  Google Scholar 

  36. Hengge UR, Currie B, Jäger G et al. (in press) Scabies – an ubiquitous neglected skin disease. Lancet Infect Dis in press

  37. Ikediobi NI, Tyring SK (2002) Cutaneous manifestations of Epstein-Barr virus infection. Dermatol Clin 20: 283–289

    Article  PubMed  Google Scholar 

  38. International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92: 1823–1830

    Article  PubMed  Google Scholar 

  39. Kaspari M, Gutzmer R, Kaspari T et al. (2002) Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma. Br J Dermatol 147: 757–759

    Article  PubMed  Google Scholar 

  40. Koutsky LA, Ault KA, Wheeler CM et al. (2002) Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651

    Article  PubMed  Google Scholar 

  41. Liautaud B, Pape JW, DeHovitz JA (1989) Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 125: 629–632

    Article  PubMed  Google Scholar 

  42. Lilie HM, Wassilew SW (2004) Varicella-zoster virus infections. Hautarzt 55: 831–840

    Article  PubMed  Google Scholar 

  43. Mallon E, Bunker CB (2000) HIV-associated psoriasis. AIDS Patient Care STDS 14: 239–246

    Article  PubMed  Google Scholar 

  44. Maurer T, Rodrigues LK, Ameli N et al. (2004) The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis 38: 579–584

    Article  PubMed  Google Scholar 

  45. Murakawa GJ, Kerschmann R, Berger T (1996) Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Dermatol 132: 545–548

    Article  PubMed  Google Scholar 

  46. Nervi SJ, Schwartz RA, Dmochowski M (2006) Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol 55: 285–289

    PubMed  Google Scholar 

  47. Nikkels AF, Snoeck R, Rentier B, Pierard GE (1999) Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects. Clin Exp Dermatol 24: 346–353

    Article  PubMed  Google Scholar 

  48. Palefsky JM, Holly EA, Ralston ML, Jay N (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177: 361–367

    PubMed  Google Scholar 

  49. Palefsky JM, Holly EA, Ralston ML et al. (2001) Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 28: 422–428

    PubMed  Google Scholar 

  50. Palefsky JM, Holly EA, Efirdc JT et al. (2005) Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19: 1407–1414

    Article  PubMed  Google Scholar 

  51. Peng Z, Simons FE (2004) Mosquito allergy: immunmechanisms and recombinant salivary allergens. Int Arch Allergy Immunol 133: 198–209

    Article  PubMed  Google Scholar 

  52. Resneck JS Jr, Van Beek M, Furmanski L et al. (2004) Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 292: 2614–2621

    Article  PubMed  Google Scholar 

  53. Rinne D, Linhart C, Schofer H (2000) Lip papillomatosis in immunodeficiency: therapy with imiquimod. Br J Dermatol 142: 196–197

    Article  PubMed  Google Scholar 

  54. Rodrigues LK, Klencke BJ, Vin-Christian K et al. (2002) Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol 138: 765–770

    Article  PubMed  Google Scholar 

  55. Saiag P, Bourgault-Villada I, Pavlovic M, Roudier-Pujol C (2002) Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy. AIDS 16: 1438–1440

    Article  PubMed  Google Scholar 

  56. Schwartz RA, Janusz CA, Janninger CK (2006) Seborrheic dermatitis: an overview. Am Fam Physician 74: 125–130

    PubMed  Google Scholar 

  57. Singh F, Rudikoff D (2003) HIV-associated pruritus: etiology and management. Am J Clin Dermatol 4: 177–88

    Article  PubMed  Google Scholar 

  58. Smith KJ, Skelton H (2002) Molluscum contagiosum: recent advances in pathogenic mechanisms, and new therapies. Am J Clin Dermatol 3: 535–545

    Article  PubMed  Google Scholar 

  59. Sobhani I, Vuagnat A, Walker F et al. (2001) Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 125: 857–866

    Article  Google Scholar 

  60. Stone K, Becker T, Hadgu A, Kraus S (1990) Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med 66: 16–19

    PubMed  Google Scholar 

  61. Subramanian S, Mathai D (2005) Clinical manifestations and management of cryptococcal infection. J Postgrad Med 51: S21–26

    PubMed  Google Scholar 

  62. Syrjänen K, Syrjänen S (2003) HPV bei Erkrankungen der Mundhöhle. In: Hengge UR (Hrsg) HPV-Infektion und Neoplasien der Haut. Unimed, Bremen, S 130–140

  63. Tollesson A, Fritz A, Berg A, Karlman G (1993) Essential fatty acids in infantile seborrheic dermatitis. J Am Acad Dermatol 28: 957–961

    PubMed  Google Scholar 

  64. Wilkins K, Turner R, Dolev JC et al. (2006) Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol 54: 189–206

    Article  PubMed  Google Scholar 

  65. Zancanaro PC, McGirt LY, Mamelak AJ et al. (2006) Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol 54: 581–588

    Article  PubMed  Google Scholar 

  66. Zhang P, Chiriboga L, Jacobson M et al. (1995) Mycosis fungoides like T-cell cutaneous lymphoid infiltrates in patients with HIV infection. Am J Dermatopathol 17: 29–35

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. R. Hengge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hengge, U.R., Mota, R. & Marini, A. Häufige und seltene dermatologische Erkrankungen bei HIV-Patienten. Hautarzt 57, 975–987 (2006). https://doi.org/10.1007/s00105-006-1239-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-006-1239-z

Schlüsselwörter

Keywords

Navigation